According to our (Global Info Research) latest study, the global 0.9% Sodium Chloride Injection market size was valued at US$ 14370 million in 2025 and is forecast to a readjusted size of US$ 20250 million by 2032 with a CAGR of 5.1% during review period.
Sodium chloride is an electrolyte supplement. Sodium and chlorine are important electrolytes in the body, which mainly exist in the extracellular fluid and play a very important role in maintaining the normal volume and osmotic pressure of blood and extracellular fluid. The concentration of normal serum Na+is 135~145mmol/L, accounting for 92% of plasma cation and 90% of total osmotic pressure. Therefore, the amount of plasma sodium plays a decisive role in osmotic pressure. The normal serum Cl - concentration is 98 ~ 106mmol/L. Sodium and chloride ions in human body are mainly regulated by hypothalamus, posterior pituitary and kidney to maintain the stability of body fluid volume and osmotic pressure. The injection concentration is usually 0.9%. This report studies the 0.9% concentration of sodium chloride injection.
This report is a detailed and comprehensive analysis for global 0.9% Sodium Chloride Injection market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global 0.9% Sodium Chloride Injection market size and forecasts, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/K Unit), 2021-2032
Global 0.9% Sodium Chloride Injection market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/K Unit), 2021-2032
Global 0.9% Sodium Chloride Injection market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/K Unit), 2021-2032
Global 0.9% Sodium Chloride Injection market shares of main players, shipments in revenue ($ Million), sales quantity (M Units), and ASP (US$/K Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for 0.9% Sodium Chloride Injection
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global 0.9% Sodium Chloride Injection market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sichuan Kelun Pharmaceutical Co.,Ltd., Hangzhou Minsheng Pharmaceutical Co., Ltd., Jiangsu Hengrui Pharmaceuticals Co.,ltd., SSY Group Limited, Jiangsu Sihuan Bioengineering Co.,Ltd., China Resources Double-crane Pharmaceutical Co.,Ltd., Sichuan Biokin Pharmaceutical Co.,Ltd., Anhui Fengyuan Pharmaceutical Co.,Ltd., Cisen Pharmaceutical, Tonghua Golden-horse Pharmaceutical Industry Co.,ltd., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
0.9% Sodium Chloride Injection market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
100ml
250ml
500ml
Other
Market segment by Application
Hospitals
Clinics
Others
Major players covered
Sichuan Kelun Pharmaceutical Co.,Ltd.
Hangzhou Minsheng Pharmaceutical Co., Ltd.
Jiangsu Hengrui Pharmaceuticals Co.,ltd.
SSY Group Limited
Jiangsu Sihuan Bioengineering Co.,Ltd.
China Resources Double-crane Pharmaceutical Co.,Ltd.
Sichuan Biokin Pharmaceutical Co.,Ltd.
Anhui Fengyuan Pharmaceutical Co.,Ltd.
Cisen Pharmaceutical
Tonghua Golden-horse Pharmaceutical Industry Co.,ltd.
Anhui Changjiang Pharmaceutical Co., Ltd.
PKU HealthCare Corp.,Ltd.
CHENGDU BRILLIANT PHARMACEUTICAL CO., LTD.
Hebei TIANCHENG Pharmaceutical Co., Ltd.
Southwest Pharmaceutical Co., Ltd.
Pfizer
Amphastar
AstraZeneca plc.
Fresenius Kabi
Baxter
Otsuka Pharmaceutical
Novartis
BBraun
Huaren Pharmaceutical Co.,Ltd.
Jilin Province Dubang Pharmaceuticals Co., Ltd.
Jiangsu Suzhong PHARMA Group Co., Ltd.
Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd.
Shandong Weigao Pharmaceutical Co., Ltd.
Shanghai Fosun Pharmaceutical(Group)Co.,Ltd.
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe 0.9% Sodium Chloride Injection product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of 0.9% Sodium Chloride Injection, with price, sales quantity, revenue, and global market share of 0.9% Sodium Chloride Injection from 2021 to 2026.
Chapter 3, the 0.9% Sodium Chloride Injection competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the 0.9% Sodium Chloride Injection breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and 0.9% Sodium Chloride Injection market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of 0.9% Sodium Chloride Injection.
Chapter 14 and 15, to describe 0.9% Sodium Chloride Injection sales channel, distributors, customers, research findings and conclusion.
Summary:
Get latest Market Research Reports on 0.9% Sodium Chloride Injection. Industry analysis & Market Report on 0.9% Sodium Chloride Injection is a syndicated market report, published as Global 0.9% Sodium Chloride Injection Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of 0.9% Sodium Chloride Injection market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.